Sign In

David Hansen

President and CEO at MabVax Therapeutics

J. David Hansen is a seasoned corporate executive with over two decades of experience in the biopharmaceutical industry.

As the President, Chief Executive Officer, and Board Member of MabVax Therapeutics since its establishment in 2006, Mr. Hansen has played a pivotal role in shaping the company's growth and success.

With a background in molecular biology and biochemistry from the University of Oregon, Mr. Hansen brings a solid scientific foundation to his leadership role.

During his tenure at Avanir Pharmaceuticals from 1998 to 2006, Mr. Hansen held various high-ranking positions, showcasing his expertise in commercial development, corporate strategy, and operations.

Mr. Hansen's extensive career also includes management roles at Dura Pharmaceuticals, Merck & Co., Key Pharmaceuticals, and Bristol Myers Squibb, further demonstrating his versatility and adaptability in the pharmaceutical sector.

His proficiency spans multiple therapeutic areas, notably oncology and immunology, underscoring his diverse knowledge and experience in the field.

Mr. Hansen's strategic acumen is evidenced by his track record in in-licensing, out-licensing, product acquisition, and new product planning, highlighting his instrumental role in driving business growth and innovation.

With a proven track record of building and leading both start-up ventures and key departments within established companies, Mr. Hansen's leadership capabilities have been instrumental in steering organizations towards success.

As the head of MabVax Therapeutics, Mr. Hansen continues to leverage his wealth of experience to advance the company's mission of developing innovative biopharmaceutical solutions.

David Hansen
Add to my network

Location

San Diego, California